Difference between revisions of "ERF of PFAS"

From Opasnet
Jump to: navigation, search
(Data)
(Data)
 
Line 22: Line 22:
 
PFAS|PFAS TWI|Maternal exposure via ingestion|ng /kg /wk|TWI|BW|0|4.4|EFSA 2020
 
PFAS|PFAS TWI|Maternal exposure via ingestion|ng /kg /wk|TWI|BW|0|4.4|EFSA 2020
 
PFAS|Immunosuppression2|Maternal ingested intake|ng /kg /wk|ERS|BW|0|0-0.0454|Converted from the row above assuming linearity and steady state
 
PFAS|Immunosuppression2|Maternal ingested intake|ng /kg /wk|ERS|BW|0|0-0.0454|Converted from the row above assuming linearity and steady state
PFAS|Immunosuppression|Infant's blood concentratioin|ng /ml|RR|Log10|0.301 - 0.699|6.863 (1.473 - 36.01)|Grandjean, 2012
+
PFAS|Immunosuppression|Infant's blood concentratioin|ng /ml|RR|Log10|0.477 - 1.477|6.863 (1.473 - 36.01)|Grandjean, 2012
 
PFAS|Cholesterol increase|Ingestion|ng /kg /wk|ERS|BW|0|0|EFSA?
 
PFAS|Cholesterol increase|Ingestion|ng /kg /wk|ERS|BW|0|0|EFSA?
 
PFAS|Decreased birth weight|Ingestion|ng /kg /wk|ERS|BW|0|0|EFSA?
 
PFAS|Decreased birth weight|Ingestion|ng /kg /wk|ERS|BW|0|0|EFSA?
Line 28: Line 28:
 
</t2b>
 
</t2b>
  
Immunosuppression is not well quantified. Here we assume that at the tolerable weekly intate (TWI) level, 0-20 % of respiratory infections are attributable to PFAS. Although age is not specified in the table, PFAS exposure is highest in infants due to pregnancy and breast feeding. Therefore we assume that immunosuppression occurs mainly at ages 0-9 a. The TWI comes from EFSA<ref>EFSA. (2020) Risk to human health related to the presence of perfluoroalkyl substances in food. https://doi.org/10.2903/j.efsa.2020.6223</ref>.
+
Immunosuppression is not well quantified. Here we assume that at the tolerable weekly intate (TWI) level, 0-20 % of respiratory infections are attributable to PFAS. Although age is not specified in the table, PFAS exposure is highest in infants due to pregnancy and breast feeding. Therefore we assume that immunosuppression occurs mainly at ages 0-9 a. The TWI comes from EFSA<ref name="efsa2020">EFSA. (2020) Risk to human health related to the presence of perfluoroalkyl substances in food. https://doi.org/10.2903/j.efsa.2020.6223</ref>.
  
 
Several studies show that increased PFAS compounds reduce the immunoresponse of diphteria, tetanus, or other vaccines. Some ERFs are listed here. Grandjean (2012)<ref name="grandjean2012">Grandjean P, Andersen EW, Budtz‐Jorgensen E, Nielsen F, Molbak K, Weihe P and Heilmann C, 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA, 307, 391–397. https://doi.org/10.1001/jama.2011.2034</ref> showed –39% (95%CI: –55, –17) and –21% (95%CI: –38, 1) decrease in diphtheria antibody concentrations at 5 years pre‐ and post‐booster, respectively, related to doubling of PFAS concentration (average 27.3 ng/ml in maternal serum). A twofold increase in maternal concentrations of combined PFOS, PFHxS, and PFOA during pregnancy was significantly associated with ‐48% (95%CI: –68, –16) and –42% (95%CI: –66, –1) decrease in serum antibody response to diphtheria at age 5 pre‐booster and age 7.5 post‐booster, respectively. No associations were observed for tetanus. The same analysis was done with offspring serum concentrations: A twofold increase in combined exposure at age 5.0 years pre‐booster was associated with a −44% (95%CI: −66, −11) and −55% (95%CI: −73, −25) decrease in serum antibody response to diphtheria and tetanus at age 7.5, respectively.  
 
Several studies show that increased PFAS compounds reduce the immunoresponse of diphteria, tetanus, or other vaccines. Some ERFs are listed here. Grandjean (2012)<ref name="grandjean2012">Grandjean P, Andersen EW, Budtz‐Jorgensen E, Nielsen F, Molbak K, Weihe P and Heilmann C, 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA, 307, 391–397. https://doi.org/10.1001/jama.2011.2034</ref> showed –39% (95%CI: –55, –17) and –21% (95%CI: –38, 1) decrease in diphtheria antibody concentrations at 5 years pre‐ and post‐booster, respectively, related to doubling of PFAS concentration (average 27.3 ng/ml in maternal serum). A twofold increase in maternal concentrations of combined PFOS, PFHxS, and PFOA during pregnancy was significantly associated with ‐48% (95%CI: –68, –16) and –42% (95%CI: –66, –1) decrease in serum antibody response to diphtheria at age 5 pre‐booster and age 7.5 post‐booster, respectively. No associations were observed for tetanus. The same analysis was done with offspring serum concentrations: A twofold increase in combined exposure at age 5.0 years pre‐booster was associated with a −44% (95%CI: −66, −11) and −55% (95%CI: −73, −25) decrease in serum antibody response to diphtheria and tetanus at age 7.5, respectively.  
  
Not all PFAS compounds and not all vaccine responses showed systematic effect. However, several combinations do, so it is assumed here that the effect is real and is close to the ERF of infant's PFAS concentration on diphtheria. Percentage changes expressed as relative risks (RR) are 0.56 (0.34 - 0.89). Doubling of a concentration means log10(2) = 0.301 addition on a log10 scale. Therefore, the beta = ln(RR) should be multiplied by 1/0.301 to get change per one unit log10, i.e. ten-fold increase. This brings us to exp(ln(0.56)/log10(2)) = 0.146, exp(ln(0.34)/log10(2)) = 0.0278, and exp(ln(0.89)/log10(2)) = 0.679. If we assume that 10 % decrease in immunoglobulin produces 10 % risk in infection, we get the inverse of these numbers, i.e. 6.863 (1.473 - 36.01).
+
Not all PFAS compounds and not all vaccine responses showed systematic effect. However, several combinations do, so it is assumed here that the effect is real and is close to the ERF of infant's PFAS concentration on diphtheria. Percentage changes expressed as relative risks (RR) are 0.56 (0.34 - 0.89). Doubling of a concentration means log10(2) = 0.301 addition on a log10 scale. Therefore, the beta = ln(RR) should be multiplied by 1/0.301 to get change per one unit log10, i.e. ten-fold increase. This brings us to exp(ln(0.56)/log10(2)) = 0.146, exp(ln(0.34)/log10(2)) = 0.0278, and exp(ln(0.89)/log10(2)) = 0.679. If we assume that the relationship between immunoglobulin concentration and and infection risk is linear, i.e. that 10 % decrease in immunoglobulin produces 10 % increase in risk of infection, we get the inverse of these numbers, i.e. the relative risk is  6.863 (1.473 - 36.01).
  
According to [[Infant's indirect exposure]], 1 ng/d of mother's PFAS intake results in 0.056 ng/ml in infant's blood. Put the other way round, 1 ng/ml in infant's blood is a result of 17.8 ng/d intake by the mother. Similarly, the TWI intake of 4.4 ng/kg/wk * 70 kg / 7 d/wk = 44 ng/d results in 2.47 ng/ml in infant's blood, say 2-5 ng/ml or on log10 scale 0.301 - 0.699. This may be a reasonable threshold for the response. A threshold is needed because the effects in EFSA report<ref name="efsa2020"/> are reported as X % decrease in the immunoglobulin concentration per doubling of the PFAS concentration. On a log x axis, this produces a straight line but, without a threshold, the immunoglobulin concentrations would theoretically increase to infinity as the PFAS concentration approaches zero. A practical threshold should be placed to an area that contains the lower levels of observed PFAS concentrations.
+
According to [[Infant's indirect exposure]], 1 ng/d of mother's PFAS intake results in 0.056 ng/ml in infant's blood. Put the other way round, 1 ng/ml in infant's blood is a result of 17.8 ng/d intake by the mother. Similarly, the TWI intake of 4.4 ng/kg/wk * 70 kg / 7 d/wk = 44 ng/d results in 2.47 ng/ml in infant's blood, and this may be considered as a threshold for the effect. Another way to estimate a threshold is to look at NOAEC. A cohort with 101 infants from Germany found that the NOAECs for PFOA, estimated by dividing exposure into quintiles, ranged between 18.9 and 19.4 ng/mL, depending on the type of antibody titres<ref>Abraham K, Mielke H, Fromme H, Volkel W, Menzel J, Peiser M, Zepp F, Willich SN and Weikert C, 2020. Internal exposure to perfluoroalkyl substances (PFASs) and biological marker in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Archives of Toxicology, 94, 2131–2147.</ref>. CONTAM panel identified an NOAEC at serum level at the age of 5 years for the sum of PFOA, PFNA, PFHxS and PFOS of 27.0 ng/mL<ref name="efsa2020"/>. Therefore, there could be a threshold in a range of 3 - 30 ng/ml for sum of PFAS. That is equal to 0.477 - 1.477 on log10 scale. This may be a reasonable threshold for the response. A threshold is needed because the effects in EFSA report<ref name="efsa2020"/> are reported as X % decrease in the immunoglobulin concentration per doubling of the PFAS concentration. On a log x axis, this produces a straight line but, without a threshold, the immunoglobulin concentrations would theoretically increase to infinity as the PFAS concentration approaches zero. A practical threshold should be placed to an area that contains the lower levels of observed PFAS concentrations.
  
 
=== Calculations ===
 
=== Calculations ===

Latest revision as of 10:10, 29 March 2021


Progression class
In Opasnet many pages being worked on and are in different classes of progression. Thus the information on those pages should be regarded with consideration. The progression class of this page has been assessed:
This page is a draft
The relevat content and structure of the page is already present, but there still is a lot of missing content.
This page needs a curator. Learn more about curating Opasnet pages.

The quality was last checked: 2021-01-29.


Question

What are the exposure-response functions (ERF) of perfluorinated alkyl substances (PFAS) on several health endpoints?

Answer

Rationale

Data

Difference between revisions of "ERF of PFAS"(-)
ObsExposure agentResponseExposureExposure unitER functionScalingThresholdERFDescription
1PFASPFAS TWIMaternal exposure via ingestionng /kg /wkTWIBW04.4EFSA 2020
2PFASImmunosuppression2Maternal ingested intakeng /kg /wkERSBW00-0.0454Converted from the row above assuming linearity and steady state
3PFASImmunosuppressionInfant's blood concentratioinng /mlRRLog100.477 - 1.4776.863 (1.473 - 36.01)Grandjean, 2012
4PFASCholesterol increaseIngestionng /kg /wkERSBW00EFSA?
5PFASDecreased birth weightIngestionng /kg /wkERSBW00EFSA?
6PFASIncreased ALTIngestionng /kg /wkERSBW00EFSA?

Immunosuppression is not well quantified. Here we assume that at the tolerable weekly intate (TWI) level, 0-20 % of respiratory infections are attributable to PFAS. Although age is not specified in the table, PFAS exposure is highest in infants due to pregnancy and breast feeding. Therefore we assume that immunosuppression occurs mainly at ages 0-9 a. The TWI comes from EFSA[1].

Several studies show that increased PFAS compounds reduce the immunoresponse of diphteria, tetanus, or other vaccines. Some ERFs are listed here. Grandjean (2012)[2] showed –39% (95%CI: –55, –17) and –21% (95%CI: –38, 1) decrease in diphtheria antibody concentrations at 5 years pre‐ and post‐booster, respectively, related to doubling of PFAS concentration (average 27.3 ng/ml in maternal serum). A twofold increase in maternal concentrations of combined PFOS, PFHxS, and PFOA during pregnancy was significantly associated with ‐48% (95%CI: –68, –16) and –42% (95%CI: –66, –1) decrease in serum antibody response to diphtheria at age 5 pre‐booster and age 7.5 post‐booster, respectively. No associations were observed for tetanus. The same analysis was done with offspring serum concentrations: A twofold increase in combined exposure at age 5.0 years pre‐booster was associated with a −44% (95%CI: −66, −11) and −55% (95%CI: −73, −25) decrease in serum antibody response to diphtheria and tetanus at age 7.5, respectively.

Not all PFAS compounds and not all vaccine responses showed systematic effect. However, several combinations do, so it is assumed here that the effect is real and is close to the ERF of infant's PFAS concentration on diphtheria. Percentage changes expressed as relative risks (RR) are 0.56 (0.34 - 0.89). Doubling of a concentration means log10(2) = 0.301 addition on a log10 scale. Therefore, the beta = ln(RR) should be multiplied by 1/0.301 to get change per one unit log10, i.e. ten-fold increase. This brings us to exp(ln(0.56)/log10(2)) = 0.146, exp(ln(0.34)/log10(2)) = 0.0278, and exp(ln(0.89)/log10(2)) = 0.679. If we assume that the relationship between immunoglobulin concentration and and infection risk is linear, i.e. that 10 % decrease in immunoglobulin produces 10 % increase in risk of infection, we get the inverse of these numbers, i.e. the relative risk is 6.863 (1.473 - 36.01).

According to Infant's indirect exposure, 1 ng/d of mother's PFAS intake results in 0.056 ng/ml in infant's blood. Put the other way round, 1 ng/ml in infant's blood is a result of 17.8 ng/d intake by the mother. Similarly, the TWI intake of 4.4 ng/kg/wk * 70 kg / 7 d/wk = 44 ng/d results in 2.47 ng/ml in infant's blood, and this may be considered as a threshold for the effect. Another way to estimate a threshold is to look at NOAEC. A cohort with 101 infants from Germany found that the NOAECs for PFOA, estimated by dividing exposure into quintiles, ranged between 18.9 and 19.4 ng/mL, depending on the type of antibody titres[3]. CONTAM panel identified an NOAEC at serum level at the age of 5 years for the sum of PFOA, PFNA, PFHxS and PFOS of 27.0 ng/mL[1]. Therefore, there could be a threshold in a range of 3 - 30 ng/ml for sum of PFAS. That is equal to 0.477 - 1.477 on log10 scale. This may be a reasonable threshold for the response. A threshold is needed because the effects in EFSA report[1] are reported as X % decrease in the immunoglobulin concentration per doubling of the PFAS concentration. On a log x axis, this produces a straight line but, without a threshold, the immunoglobulin concentrations would theoretically increase to infinity as the PFAS concentration approaches zero. A practical threshold should be placed to an area that contains the lower levels of observed PFAS concentrations.

Calculations

Initiation 2021-01-29

+ Show code

See also

References

  1. 1.0 1.1 1.2 EFSA. (2020) Risk to human health related to the presence of perfluoroalkyl substances in food. https://doi.org/10.2903/j.efsa.2020.6223
  2. Grandjean P, Andersen EW, Budtz‐Jorgensen E, Nielsen F, Molbak K, Weihe P and Heilmann C, 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA, 307, 391–397. https://doi.org/10.1001/jama.2011.2034
  3. Abraham K, Mielke H, Fromme H, Volkel W, Menzel J, Peiser M, Zepp F, Willich SN and Weikert C, 2020. Internal exposure to perfluoroalkyl substances (PFASs) and biological marker in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Archives of Toxicology, 94, 2131–2147.